首页 >
法规速递
-
Document: Medicinal products for human use: monthly figures - August 2025-2025/9/9
2025-09-10查看详情 > -
Document: Timetable: Post-authorisation measure (PAM) assessed by PRAC-2025/10/14
2025-10-15查看详情 > -
Document: Scientific advice and protocol assistance adopted during the CHMP meeting 13-16 October 2025-2025/11/18
2025-11-19查看详情 > -
Document: Guideline on the clinical investigation of medicinal products in the treatment of patients with acute respiratory distress syndrome - Revision 2-2025/12/12
2025-12-15查看详情 > -
Page: Clinical investigation of medicinal products in the treatment of peripheral-arterial occlusive disease - Scientific guideline-2026/1/27
2026-01-28查看详情 > -
New Clinical Investigation Exclusivity (3-Year Exclusivity) for Drug Products: Questions and Answers-2026/3/3
2026-03-05查看详情 > -
Page: Core summary of product characteristics for human normal immunoglobulin for subcutaneous and intramuscular use - Scientific guideline-2026/4/1
2026-04-02查看详情 > -
Document: Questions and answers - Practical arrangements on the companion diagnostics consultation procedure to the European Medicines Agency by notified bodies-2026/5/18
2026-05-19查看详情 > -
国家药监局综合司 海关总署办公厅关于增设石家庄航空口岸为药品进口口岸有关事宜的通知 药监综药注〔2022〕91号-2022/11/22
2022-11-30查看详情 > -
国家药监局关于实施《药物非临床研究质量管理规范认证管理办法》有关事宜的公告（2023年第81号）-2023/6/21
2023-06-21查看详情 >
